Kathy S. Albain, MD

Articles by Kathy S. Albain, MD

31 TIP TROPION-Breast03: Datopotamab Deruxtecan (Dato-DXd) ± Durvalumab vs Investigator’s Choice of Therapy (ICT) for Triple-Negative Breast Cancer (TNBC) with Residual Disease Following Neoadjuvant Therapy

ByAditya Bardia, MD, MPH, FASCO,Lajos Pusztai, MD, DPhil,Kathy S. Albain, MD,Kevin Kalinsky, MD, MS,Dawn Herman,William Barlow,Claudine Isaacs, MD,Micah Maxwell,Nadia Harbeck, MD, PhD,Priyanka Sharma, MD

April 27th 2023

Induction Chemotherapy With/Without Radiation Followed by Surgery in Stage III Non-Small-Cell Lung Cancer

ByKathy S. Albain, MD

September 1st 1997

The objectives of this review are to provide an update and perspectives on the use of induction therapy (chemotherapy with or without radiotherapy) followed by surgery in two subgroups of patients with stage III non-

Latest Updated Articles

Induction Chemotherapy With/Without Radiation Followed by Surgery in Stage III Non-Small-Cell Lung Cancer
Published: September 1st 1997 | Updated:

Kathy S. Albain, MD

Articles by Kathy S. Albain, MD

31 TIP TROPION-Breast03: Datopotamab Deruxtecan (Dato-DXd) ± Durvalumab vs Investigator’s Choice of Therapy (ICT) for Triple-Negative Breast Cancer (TNBC) with Residual Disease Following Neoadjuvant Therapy

Induction Chemotherapy With/Without Radiation Followed by Surgery in Stage III Non-Small-Cell Lung Cancer

Latest Updated Articles

Trending on CancerNetwork

Modifiable Risk Factors Suggest Potential for Improving Cancer Prevention

Barriers to CAR T-Cell Referral and Center Access in Multiple Myeloma

2026 Tandem Meetings: What’s the Latest Research in Multiple Myeloma?

Real World Outcomes of CAR T-Cell Therapy in Multiple Myeloma Including Older and Comorbid Patients

Exploring The Impact of ADTs on Cardiac Risk in Prostate Cancer Treatment